Skip to main content
CMPS
NASDAQ Life Sciences

Compass Narrows Q3 Loss to $9.8M, Final NDA Filing Due Within Two Weeks

Tom Rudovsky · Reported by BusinessWire
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$9.5
Mkt Cap
$1.165B
52W Low
$4.88
52W High
$15.87
52W Position info
95% above low
Off High info
40% below high
Rel. Volume info
5.8× avg
Market data snapshot near publication time

CMPS sits 95% above its 52-week low of $4.88 on elevated volume (5.8× avg).

Summary

Compass reported a Q3 net loss of $9.8 million, or 31c per share, versus $137.7 million a year earlier — the swing is mostly a $40.8 million non-cash warrant fair-value gain, not operations. The operating picture is a company pivoting to launch: R&D fell to $23.5 million from $27.3 million as Phase 3 TRD costs wound down, while SG&A jumped to $33.0 million from $13.2 million on commercial buildout. Cash stands at $444.0 million, up from $149.6 million at year-end, and management says that funds operations into 2028. The real news is regulatory timing: the rolling NDA for COMP360 in TRD is nearly complete, with the final submission due in the next two weeks, and the National Priority Voucher could compress FDA review to 1-2 months ahead of an H1 2027 launch. This follows the September 52-week COMP005 data and the 26-week Phase 3 readout in July that built the filing package.

At the time of this announcement, CMPS was trading at $9.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $4.88 to $15.87. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

CMPS - Latest Insights

CMPS
Nov 09, 2026, 6:30 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $8.90
Real-time Price: $8.17 info
Change: -$0.730 (-8%) info
Market Cap: $1.131B info
CMPS
Nov 03, 2026, 8:07 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $9.21
Real-time Price: $8.17 info
Change: -$1.04 (-11%) info
Market Cap: $1.131B info
CMPS
Sep 23, 2026, 3:15 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $14.75
Real-time Price: $8.17 info
Change: -$6.58 (-45%) info
Market Cap: $1.131B info
CMPS
Sep 09, 2026, 1:18 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $15.30
Real-time Price: $8.17 info
Change: -$7.13 (-47%) info
Market Cap: $1.131B info
CMPS
Aug 05, 2026, 6:30 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.84
Real-time Price: $8.17 info
Change: -$3.67 (-31%) info
Market Cap: $1.131B info